The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.50
Ask: 19.50
Change: -0.25 (-1.30%)
Spread: 1.00 (5.405%)
Open: 19.25
High: 19.25
Low: 19.00
Prev. Close: 19.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Thu, 04th Mar 2021 11:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Futura Medical, up 22% at 20.08 pence, 12-month range 7.16p-24.49p. The pharmaceutical company says it has entered into financing transactions with HT Riverwood Multi-Growth Fund which will provide the company with up to GBP2 million in cash, GBP1.5 million of which has been received.

----------

Franchise Brands, up 7.7% at 109.30p, 12-month range 81p-136.65p. Says it saw a resilient performance through lockdowns and a robust recovery in second half. For 2020, revenue increases by 12% to GBP49.3 million from GBP44.0 million in 2019 and pretax profit increases to GBP3.7 million from GBP3.3 million. Franchise Brands ups final dividend to 0.80p per share from 0.65p paid in 2019.

----------

ThinkSmart, up 6.7% at 77.9p, 12-month range 12p-91.5p. The digital payments business posts rise in interim earnings. For six months to December 31, pretax profit surges to GBP53.7 million from GBP16.0 million after financial instruments gains. ThinkSmart pays 3.4p per share special dividend and capital return in December.

----------

AIM - LOSERS

----------

MediaZest, down 16% at 0.080p, 12-month range 0.01p-0.18p. The audio-visual company says financial results for the eighteen-month period were affected substantially by the Covid-19 pandemic, with reduction in revenue particularly during the first UK lockdown. Revenue GP3.1 million, down from GBP3.3 million year before and swings to GBP478,000 pretax loss from GBP6,000 profit.

----------

Angle, down 9.7% at 79.30p, 12-month range 37.15p-98p. The liquid biopsy company says it has received response from US Food & Drug Administration after requesting clearance for its Parsortix treatment. Says FDA has indicated its review processes for non Covid-19 devices are currently slower than usual due to pandemic priorities. Notes that FDA processes are outside the company's control and it is continuing to expedite all aspects of the process which are under its control in line with previously advised timescales.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Mar 2021 15:39

Angle completes clinical labs in Guildford and Pennsylvania

(Sharecast News) - Liquid biopsy company Angle has completed the fitout and staffing of its clinical services laboratories in Guildford and Pennsylvania, it announced on Tuesday.

Read more
4 Mar 2021 19:32

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

Read more
18 Feb 2021 10:24

Angle Shares Jump On Recent Parsortix System Research Results

Angle Shares Jump On Recent Parsortix System Research Results

Read more
8 Feb 2021 17:09

IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix

IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix

Read more
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
20 Jan 2021 12:22

Angle Reports Parsortix System Can Isolate Circulating Tumour Cells

Angle Reports Parsortix System Can Isolate Circulating Tumour Cells

Read more
20 Jan 2021 10:40

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

Read more
3 Nov 2020 15:53

DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares

DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares

Read more
29 Oct 2020 14:46

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

Read more
27 Oct 2020 19:06

UPDATE: Angle Successfully Raises GBP20 Million In Placing

UPDATE: Angle Successfully Raises GBP20 Million In Placing

Read more
27 Oct 2020 12:37

IN BRIEF: Angle To Raise GBP20 Million To Fund Operations

IN BRIEF: Angle To Raise GBP20 Million To Fund Operations

Read more
22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Oct 2020 14:18

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

Read more
20 Oct 2020 08:58

FDA accepts Angle's review submission for Parsortix PC1

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.